MedTech Business Review: Specials Magazine

Medical device OEMs looking to nearshore their production no longer need to compromise between speed and global-grade rigor. BMC Medical Manufacturing has made that balance possible from Monterrey, positioning Latin America as a credible center for high-complexity medical device production. By bringing the discipline of global manufacturers together with the responsiveness of a nearshore partner, it delivers a standard that few can match. BMC is the only manufacturer in Mexico to operate under a full regulatory trifecta that includes ISO 13485 certification, FDA registration and GMP compliance with both Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) in Mexico and Agência Nacional de Vigilância Sanitária (ANVISA) in Brazil. The recent achievement of ANVISA GMP elevates its relevance across the region. It differentiates them from other manufacturers, places them ahead of the ongoing COFEPRIS-ANVISA harmonization, and helps clients expand into Brazil and broader LATAM markets through one unified, audit-ready platform. Located just two and a half hours from the U.S. border, BMC’s facility gives OEMs an immediate strategic advantage. Proximity reduces logistical complexity, replacing month-long ocean freight with same-day land transit and bringing lead times down to under 24 hours. That pace is supported by a vertically integrated operation where design transfer, cleanroom assembly, packaging and sterilization sit within one controlled environment built to global regulatory expectations. By keeping every step on-site and tightly coordinated, BMC links OEM design teams with production in real time while giving clients continuous visibility and control. “When a client entrusts their device, they’re handing us their reputation and, ultimately, a patient’s safety. That is why we operate with global rigor while staying as close and responsive as a local partner,” says Mario Alberto Peña, General Manager of BMC Medical Manufacturing. Whether it’s a startup working toward its first approval or an established OEM managing complex product lines, BMC begins every project by stepping in as an extension of the client’s team. The early alignment allows its engineers to focus on the intent behind the device and work with OEM partners to translate complex designs into processes that hold up under real-world manufacturing and clinical conditions. Over time, this way of working has shaped what BMC calls ‘engineering trust,’ a culture grounded in Peña’s conviction that Mexican engineering could meet the world’s highest standards.

SR Productos para la Salud S.A. has anchored Latin America’s healthcare supply chain as the region’s leading syringe and needle manufacturer for over two decades. Its strength lies in turning industrial strategy into practical innovation, leveraging Paraguay’s Maquila Project to cut production costs and reinvesting those efficiencies into affordability. That model proved decisive during COVID-19, when SR supplied nearly all of Paraguay’s syringes, secured Brazil’s national tender and stabilized prices so vaccination programs could move forward without disruption. As part of the SR Group, alongside SR Saldanha Rodrigues LTDA, the company has expanded its portfolio well beyond syringes to critical disposables such as umbilical clamps, enteral adapters, collector bottles, caps and masks, all engineered to reduce infection risks and streamline clinical procedures. Every product is manufactured under internationally recognized quality standards and good manufacturing practices, ensuring consistency across markets. “Our mission is to make excellence attainable for every healthcare institution,” says Luiz Felipe Saldanha Rodrigues, vice president. “That means pairing world-class manufacturing with responsible pricing and the agility to deliver even in crisis conditions.” This means dependable supply and simpler procurement for hospitals and clinics. For patients, it translates into safer, less traumatic care experiences. Strategic Manufacturing Footprint SR’s dual-facility approach maximizes regional advantages. The Manaus plant in Brazil capitalizes on one of the country’s most cost-efficient manufacturing zones, while the Paraguayan operation benefits from South America’s lowest operational costs. This geographic diversification is about resilience. With its logistics fleet operating from Paraguay, SR maintains direct control over delivery timelines, a critical advantage when serving healthcare systems across Brazil, Argentina, Paraguay and beyond. The company’s adaptability extends beyond logistics. Each market receives products tailored to local specifications, from packaging requirements to regulatory standards. Whether supplying epidural anesthesia equipment for specialized procedures or veterinary health solutions for agricultural regions, SR adjusts its approach without compromising quality standards..